Ospina-García N, Cervantes-Arriaga A, Rodríguez-Violante M

Language: Spanish
References: 66
Page: 94-107
PDF size: 469.09 Kb.

ABSTRACT

In the last 30 years not only have significant progress in the genetic and physiological aspects of dystonia but the diagnostic, classification and treatment approach. For years, oral medications were used exclusively, with the introduction of botulinum toxin and deep brain stimulation, in addition to advances in the understanding of the disease, it has had a positive impact on the quality of life of those who suffer from it and their families. In this article, we will carry out an integral update of the dystonia from its definition, phenomenology, classification, etiology, and treatment.

REFERENCES

1. Ozelius LJ, Lubarr N, Bressman SB. Milestones in dystonia. Mov Disord. 2011;26 (6):1106-1126.

2. Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: A systematic review and meta-analysis. Mov Disord. 2012;27 (14):1,789-1,796.

3. Alegría MA, Rodríguez VM, Zavala RA, López RM. Distonía cervical. Rev Mex Neurocienc. 2009;10 (2):90-102.

4. Troiano R, Micheli FE, Alarco F. Movement disorders in Latin America. 2006; 12:125-138.

5. Kuyper DJ, Parra V, Aerts S, Okun MS, Kluger BM. Nonmotor manifestations of dystonia: A systematic review. Mov Disord. 2011; 26 (7):1206-1217.

6. H O. About a rare spasm disease of childhood and young age (Dysbasia lordotica progressiva, dystonia musculorum deformans). Neurol Cent. 1,911; 30:1,090-1,107.

7. CD Marsden. Dystonia: The Spectrum of the Disease. Res Nerv Ment Dis. 1976; 55:351-367.

8. Albanese A. How many dystonias? Clinical evidence. Front Neurol. 2017; 8:18.

9. Fahn S ER. Definition of dystonia and classification of the dystonic states. Adv Neurol. 1976; 14:1-5.

10. Albanese A, Lalli S. Update on dystonia. Curr Opin Neurol. 2012; 25 (4):483-490.

11. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: A consensus update. Mov Disord. 2013; 28 (7):863-873.

12. Jinnah HA, Delong MR, Hallett M. The dystonias: Past, present, and future. Mov Disord. 2013; 28 (7):849-850.

13. Albanese A. Dystonia : clinical approach. 2007; 13:356-361.

14. LeDoux MS. Dystonia: phenomenology. Parkinsonism Relat Disord. 2012; 18:S162-S164.

15. Sitburana O, Chen Wu LJ, Sheffield JK, Davidson A, Jankovic J. Motor overflow and mirror dystonia. Park Relat Disord. 2009;15 (10):758-761.

16. Frucht SJ. The definition of dystonia: Current concepts and controversies. Mov Disord. 2013;28 (7):884-888.

17. Quartarone A, Hallett M. Emerging concepts in the physiological basis of dystonia. Mov Disord. 2013;28 (7):958-967.

18. Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG. The pathophysiological basis of dystonias. Nat Rev Neurosci. 2008;9 (3):222-234.

19. Kaji R, Rothwell SJC, Katayama M, Ikeda T. Tonic Vibration Reflex and Muscle Afferent Block in Writer ’ s Cramp. 1995:155-162.

20. Tinazzi M, Fiorio M, Fiaschi A, Rothwell JC, Bhatia KP. CME Sensory Functions in Dystonia : Insights from Behavioral Studies. 2009;24 (10):1427-1436.

21. Bara-Jimenez W, Shelton P, Hallett M. Spatial discrimination is abnormal in focal hand dystonia. Neurology. 2000;55 (12):1,869- 1,873.

22. Quartarone A, Bagnato S, Rizzo V, et al. Abnormal associative plasticity of the human motor cortex in writer’s cramp. Brain. 2003;126 (12):2,586-2,596.

23. Quartarone A, Pisani A. Abnormal plasticity in dystonia: Disruption of synaptic homeostasis. Neurobiol Dis. 2011;42 (2):162-170.

24. Ozelius LJ, Bressman SB. Genetic and clinical features of primary torsion dystonia. Neurobiol Dis. 2011;42 (2):127-135.

25. Klein C. Genetics in dystonia. Park Relat Disord. 2014;20 (SUPPL.1):S137-S142.

26. Xiao J, Uitti RJ, Zhao Y, et al. Mutations in CIZ1 Cause Adult Onset Primary Cervical Dystonia. 2012; 71 (4):458-469

27. Bras J, Sheerin U, Charlesworth G, et al. Mutations in ANO3 Cause Dominant Craniocervical Dystonia : Ion Channel Implicated in Pathogenesis. 2012:1,041-1,050.

28. Fuchs T, Saunders-pullman R, Masuho I, et al. Mutations in GNAL cause primary torsion dystonia. Nat Genet. 2013; 45 (1): 88–92.

29. Lohmann K, Klein C. Update on the genetics of Dystonia. Curr Neurol Neurosci Rep. 2017;17 (3):26

30. Camargos S, Cardoso F. Understanding dystonia: diagnostic issues and how to overcome them. Arq Neuropsiquiatr. 2016;74 (11):921-936.

31. Fabbrini G, Berardelli I, Moretti G, et al. Psychiatric disorders in adult-onset focal dystonia: A case-control study. Mov Disord. 2010;25 (4):459-465.

32. Lencer R, Steinlechner S, Stahlberg J, et al. Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry. 2009;80 (10):1,176-1,179.

33. Zoons E, Tijssen MAJ, Dreissen YEM, Speelman JD, Smit M, Booij J. The relationship between the dopaminergic system and depressive symptoms in cervical dystonia. Eur J Nucl Med Mol Imaging. 2017;44 (8):1,375-1,382

34. Berardelli I, Ferrazzano G, Pasquini M, Biondi M, Berardelli A, Fabbrini G. Clinical course of psychiatric disorders in patients with cervical dystonia. Psychiatry Res. 2015; 229 (1-2):583-585.

35. Zurowski M, Mcdonald WM, Fox S, Marsh L. Psychiatric comorbidities in dystonia: Emerging concepts. Mov Disord. 2013;28 (7):914-920.

36. Smit M, Kuiper A, Han V, et al. Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study. Parkinsonism Relat Disord. 2016; 30:7-12.

37. Lange F, Seer C, Dengler R, Dressler D, Kopp B. Cognitive Flexibility in Primary Dystonia. J Int Neuropsychol Soc. 2016;22 (6):662-670.

38. Adam O, Jankovic J. Treatment of dystonia. Parkinsonism Relat Disord. 2007;13 (1):94-121.

39. Burke RE FS. Double-blind evaluation of trihexyphenidyl in dystonia. Adv Neurol. 1983; 37:189-192.

40. Hwang WJ, Calne DB, Tsui JKC, Fuente-ferna R De. The long-term response to levodopa in dopa-responsive dystonia. 2001; 8:18- 22.

41. Jankovic J. Medical treatment of dystonia. Mov Disord. 2013;28 (7):1,001-1,012.

42. Woolf SM, Baum CR. Baclofen. Uses and Complications. 2017;33 (4):271-275.

43. Monbaliu E, Himmelmann K, Lin J, et al. Clinical presentation and management of dyskinetic cerebral palsy. 2017:741-749.

44. Jabbari B. Reviews History of Botulinum Toxin Treatment in Movement Disorders. 1989:1-9.

45. Müller J, Kemmler G, Wissel J, et al. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol. 2002;249 (7):842-846.

46. Su MV, Direcci REZ, Investigaci DE, et al. Impact of Neu-botulinumtoxinA on the Severity and Quality of Life of Cervical Dystonia Patients. Arq Neuropsiquiatr. 2016;10 (6):188-194.

47. Simpson DM, Hallett M, Ashman EJ, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Academy of Neurology. 2016;86 (19):1,818-1,826.

48. Jankovic J. Botulinum Toxin : State of the Art Mechanism of Action and Pharmacology of BoNT. 2017;32 (8):1-8.

49. Arango GJ, Fernández W. Indicaciones actuales para el uso de la toxina botulínica en neurología. Acta Neurologica Colombiana. 2004; 15:12-34

50. Albanese A, Asmus F, Bhatia KP, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011;18 (1):5-18.

51. Pirio Richardson S, Wegele AR, Skipper B, Deligtisch A, Jinnah HA. Dystonia treatment: Patterns of medication use in an international cohort. Neurology. 2017;88 (6):543-550.

52. Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol. 2007;6 (3):223-229.

53. Krystkowiak P, Benabid A, Ph D, et al. Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia. 2005:459-467.

54. Vidailhet M, Yelnik J, Lagrange C, et al. Bilateral pallidal deep brain stimulation for the treatment of patients with dystoniachoreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol. 2009;8 (8):709-717.

55. Volkmann J, Wolters A, Kupsch A, et al. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol. 2012;11 (12):1029-1038.

56. Gruber D, Trottenberg T, Kivi A, et al. Long-term effects of pallidal deep brain stimulation in tardive dystonia. Neurology. 2009;73 (1):53-58.

57. Marks WA, Honeycutt J, Acosta F, Reed M. Deep Brain Stimulation for Pediatric Movement Disorders. Semin Pediatr Neurol. 2009;16 (2):90-98.

58. Cersosimo MG, Raina GB, Piedimonte F, Antico J, Graff P, Micheli FE. Pallidal surgery for the treatment of primary generalized dystonia: Long-term follow-up. Clin Neurol Neurosurg. 2008;110 (2):145-150.

59. Meoni S, Fraix V, Castrioto A, et al. Pallidal deep brain stimulation for dystonia: a long term study. J Neurol Neurosurg Psychiatry. 2017:jnnp-2016-315504.

60. Moro E, Gross RE, Krauss JK. What’s new in surgical treatment for dystonia? Mov Disord. 2013;28 (7):1,013-1,020.

61. Aravamuthana Bhooma R, Waugha Jeff SSS. Deep brain stimulation for monogenic dystonia. Curr Opin Pediatr. 2017;29 (6):691- 696.

62. Bronte-Stewart H, Taira T, Valldeoriola F, et al. Inclusion and exclusion criteria for DBS in dystonia. Mov Disord. 2011;26 (SUPPL.1):5-16.

63. Thobois S, Taira T, Comella C, Moro E, Bressman S, Albanese A. Pre-operative evaluations for DBS in dystonia. Mov Disord. 2011;26 (SUPPL.1):17-26.

64. Krause M, Fogel W, Tronnier V, Pohle S, Hörtnagel K, Thyen U VJ. Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord. 2006;21 (12):2,255-2,257.

65. Patel AJ, Sarwar AI, Jankovic J VA. Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism. World Neurosurg. 2014; 82:241-244.

66. Mills KA, Starr PA, Ostrem JL. Neuromodulation for Dystonia. Target and Patient Selection. Neurosurg Clin N Am. 2014;25 (1):59-75.